đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Acute Pancreatitis Companies

Addressing pancreatic health, Acute Pancreatitis companies focus on treatment solutions for this inflammatory condition. Through research and development, they offer therapeutic interventions that alleviate symptoms and improve outcomes for patients experiencing acute pancreatitis, contributing to advancements in gastroenterology and patient care.

Acute Pancreatitis Key Companies


Latest Acute Pancreatitis Companies Update:

Danaher Corporation (US) acquired the Biopharma business of GE Life Sciences, GE Healthcare, in 2020. This move solidified Danaher's position as a major player in the life sciences segment, including cell counting technologies.

Agilent Technologies acquired BioTek Instruments, Inc. (US) in 2019. This acquisition strengthens Agilent's portfolio of cell counting tools and instruments, particularly in the microplate reader segment.

PerkinElmer entered into an agreement with Accenture in 2019 to join their Open Partner Ecosystem Program. This collaboration focuses on leveraging technology and expertise to accelerate drug discovery and improve patient outcomes, which involves precise cell counting techniques.

Thermo Fisher Scientific launched the Countess™ III Automated Cell Counter in 2023. This new instrument offers advanced features like viability staining and cell size analysis, catering to various research and clinical applications.

Merck KGaA introduced the MilliporeSigma MobiCount™ Automated Cell Counter in 2022. This portable and handheld device provides rapid cell counting for point-of-care settings, expanding accessibility and convenience.

Logos Biosystems received US FDA 510(k) clearance for its Luna-II™ Automated Cell Counter in 2023. This innovative system utilizes fluorescence microscopy for high-resolution cell imaging and counting, further enhancing accuracy and versatility.

List of Acute Pancreatitis Key companies in the market

  • CalciMedica

  • SCM Lifescience

  • Samsung Bioepis

  • GNT Pharma Co.

  • Baxter International Inc.

  • Braun Melsungen AG

  • General Electric Company

  • Medtronic

  • Boston Scientific Corporation

  • Fresenius Kabi USA

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.